Bank of Montreal Portfolio holdings
Bank of Montreal (BMO), established in 1817 as Canada’s first chartered bank and headquartered in Montreal, Quebec (with key operations in Toronto), is a major North American financial institution offering personal and commercial banking, wealth management, and capital markets services. Managing hundreds of billions in assets, BMO serves over 13 million customers, with a strong U.S. presence through BMO Harris Bank, bolstered by its 1984 acquisition of Harris Bank and the 2022 purchase of Bank of the West, expanding its footprint to 32 states. Known for its longevity and stability, BMO has paid dividends since 1829, one of the longest streaks globally, and emphasizes digital innovation and sustainable finance under CEO Darryl White. With a global reach spanning North America, Europe, and Asia, BMO blends its historical roots with a modern focus on customer-centric growth.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$219M |
| 2 |
Canadian National Railway
CNI
|
+$202M |
| 3 |
Mondelez International
MDLZ
|
+$154M |
| 4 |
ETP
Energy Transfer Partners L.p.
ETP
|
+$152M |
| 5 |
Boeing
BA
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ESRX
Express Scripts Holding Company
ESRX
|
+$532M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$260M |
| 4 |
Medtronic
MDT
|
+$240M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 28.03% |
| 2 | Miscellaneous | 11.24% |
| 3 | Energy | 9.75% |
| 4 | Healthcare | 9.48% |
| 5 | Technology | 7.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2151
Sunstone Hotel Investors
SHO
$2.11B
| $250K | ﹤0.01% |
18,909
-5,589
| -23% | -$80.5K |
2014 Q1
6 quarters
|
|
2152
Valley National Bancorp
VLY
$7.09B
| $249K | ﹤0.01% |
25,389
+50
| +0.2% | +$492 |
2013 Q2
9 quarters
|
|
|
BFX
2153
DELISTED
BowFlex Inc.
BFX
| $249K | ﹤0.01% |
16,603
-830
| -5% | -$14.9K |
2013 Q2
9 quarters
|
|
2154
Amphastar Pharmaceuticals
AMPH
$1.07B
| $248K | ﹤0.01% |
21,172
+3,880
| +22% | +$58.2K |
2014 Q3
4 quarters
|
|
2155
Great Southern Bancorp
GSBC
$858M
| $248K | ﹤0.01% |
5,723
+187
| +3% | +$7.75K |
2014 Q2
5 quarters
|
|
2156
Pegasystems
PEGA
$5.56B
| $248K | ﹤0.01% |
20,206
+386
| +2% | +$4.78K |
2013 Q2
9 quarters
|
|
|
LUMO
2157
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $248K | ﹤0.01% |
771
-434
| -36% | -$191K |
2015 Q2
1 quarter
|
|
|
BRSS
2158
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $248K | ﹤0.01% |
+12,087
| New | +$223K |
2015 Q3
0 quarters
|
|
|
EQY
2159
DELISTED
Equity One
EQY
| $248K | ﹤0.01% |
10,154
+1,812
| +22% | +$44.1K |
2013 Q2
9 quarters
|
|
2160
Eagle Bancorp
EGBN
$867M
| $247K | ﹤0.01% |
5,433
+305
| +6% | +$13.4K |
2013 Q2
9 quarters
|
|
|
NUTR
2161
DELISTED
Nutraceutical International Co
NUTR
| $246K | ﹤0.01% |
10,395
-325
| -3% | -$7.78K |
2013 Q2
9 quarters
|
|
|
VVUS
2162
DELISTED
Vivus Inc
VVUS
| $246K | ﹤0.01% |
15,000
| – | – |
2013 Q2
9 quarters
|
|
|
PGRE
2163
DELISTED
Paramount Group
PGRE
| $245K | ﹤0.01% |
14,595
-2,588
| -15% | -$44.7K |
2015 Q1
2 quarters
|
|
|
COHR
2164
DELISTED
Coherent Inc
COHR
| $245K | ﹤0.01% |
4,488
-1,295
| -22% | -$75.6K |
2013 Q2
9 quarters
|
|
|
JCP
2165
DELISTED
J.C. Penney Company, Inc.
JCP
| $245K | ﹤0.01% |
26,265
+2,639
| +11% | +$23.4K |
2013 Q2
9 quarters
|
|
2166
First Trust Senior Loan Fund ETF
FTSL
$2.43B
| $243K | ﹤0.01% |
5,021
+2,222
| +79% | +$109K |
2014 Q4
3 quarters
|
|
2167
Middleby
MIDD
$4.69B
| $242K | ﹤0.01% |
2,301
+520
| +29% | +$59.9K |
2013 Q2
9 quarters
|
|
2168
PetMed Express
PETS
$29.3M
| $242K | ﹤0.01% |
15,000
| – | – |
2015 Q2
1 quarter
|
|
|
NPKI
2169
NPK International
NPKI
$1.01B
| $242K | ﹤0.01% |
47,216
+9,423
| +25% | +$64.5K |
2013 Q2
9 quarters
|
|
|
PVG
2170
CALL
DELISTED
PRETIUM RESOURCES INC.
PVG
| $242K | ﹤0.01% |
+40,000
| New | +$206K |
2015 Q3
0 quarters
|
|
|
AVNS
2171
DELISTED
Avanos Medical
AVNS
| $241K | ﹤0.01% |
8,441
-1,053
| -11% | -$36.7K |
2015 Q1
2 quarters
|
|
2172
Healthcare Services Group
HCSG
$1.42B
| $241K | ﹤0.01% |
7,150
+1,813
| +34% | +$61.3K |
2013 Q2
9 quarters
|
|
2173
Charles River Laboratories
CRL
$13.7B
| $240K | ﹤0.01% |
3,757
+392
| +12% | +$28.1K |
2013 Q2
9 quarters
|
|
2174
iShares Select U.S. REIT ETF
ICF
$2.03B
| $240K | ﹤0.01% |
5,198
-330
| -6% | -$15.3K |
2013 Q2
9 quarters
|
|
2175
MaxLinear
MXL
$9.33B
| $240K | ﹤0.01% |
19,239
| – | – |
2013 Q2
9 quarters
|
|
Similar funds
Bank of Montreal's Q3 2015 Portfolio in Review
As of Q3 2015, Bank of Montreal held 4,426 positions worth $72.4B, down 15% from $85.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Bank of Montreal withdrew a net $5.52B in Q3 2015, closing 296 positions and reducing 1,697 holdings. Its most notable exit was KRAFT FOODS GROUP INC COM STK (VA), an estimated $260M position sold in full.
By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Miscellaneous and Energy.
Against the trend, Bank of Montreal opened a new position in PayPal worth $66.3M.
- Bank of Montreal's largest Q3 2015 buy was PayPal: 2,136,404 shares worth $66.3M.
- Bank of Montreal added most to Pfizer in Q3 2015, an estimated $219M increase.
- Bank of Montreal's biggest Q3 2015 reduction was Express Scripts Holding Company, cutting an estimated $532M.
- Bank of Montreal fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $260M.
- Bank of Montreal's ten largest holdings make up 23% of its $72.4B portfolio in Q3 2015.
- Bank of Montreal opened 378 new positions and closed 296 in Q3 2015.
- Bank of Montreal's portfolio value fell 15% quarter-over-quarter to $72.4B.
Based on Bank of Montreal's 13F filing for Q3 2015, filed 12 Nov 2015.